Your browser doesn't support javascript.
loading
Clinical observation of ocular alkali burn by Breviscapinun / 国际眼科杂志(Guoji Yanke Zazhi)
International Eye Science ; (12): 1275-1277, 2014.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-641977
Responsible library: WPRO
ABSTRACT
AlMTo find better ways of treating ocular alkali burn, and to reduce the suffering of patients and social burden.

METHODS:

Totally 100 patients were graded according to the degree of chemical burns to four major groups, each half were randomly divided into the control group and the treatment group. Control group underwent conventional treatment. ln addition to conventional therapy, patients in each treatment group were also added a Breviscapine intravenous injection of 40mg daily. Corneal recovery time, changes in vision, degree of corneal opacity, number of corneal neovascularization and other complications were observed. Curative effects were analyzed statistically.

RESULTS:

There was no significant difference in levelⅠgroup between control group and treatment group ( P>0. 05); There were significantly different in level Ⅱ, Ⅲand Ⅳ group ( P CONCLUSlON Breviscapine in the treatment of ocular alkali burns can shorten the course of treatment, reduce corneal scarring, and improve vision.

Full text: Available Database: WPRIM (Western Pacific) Language: Chinese Journal: International Eye Science Year: 2014 Document type: Article
Full text: Available Database: WPRIM (Western Pacific) Language: Chinese Journal: International Eye Science Year: 2014 Document type: Article
...